Back
Regeneron Pharmaceuticals Vs. Triumph Financial Industry Stock Comparison
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
$683.00
Seasonality Move:
3.9%
Sell
28
TFIN
Triumph Financial
Last Price:
$60.09
Seasonality Move:
-6.74%
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $680.61. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Triumph Financial (TFIN)
is a Sell
Is Triumph Financial a Buy, Sell or Hold?
-
The current Triumph Financial [TFIN] share price is $59.80. The Score for TFIN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $680.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $59.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 44.95 | Sell |
Chaikin Money Flow: | -602435 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (677.21 - 710.71) | Sell |
Bollinger Bands (100): | (666.77 - 843.93) | Sell |
TFIN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.18 | Sell |
Relative Strength Index (14 RSI): | 22.48 | Sell |
Chaikin Money Flow: | -151572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.37 - 75.47) | Sell |
Bollinger Bands (100): | (74.06 - 99.92) | Sell |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 692.72 | Sell |
20-day SMA: | 690.64 | Sell |
50-day SMA: | 696.18 | Sell |
200-day SMA: | 916.61 | Sell |
8-day EMA: | 694.28 | Sell |
20-day EMA: | 694.31 | Sell |
50-day EMA: | 710.52 | Sell |
200-day EMA: | 837.75 | Sell |
TFIN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62 | Sell |
20-day SMA: | 67.45 | Sell |
50-day SMA: | 77.46 | Sell |
200-day SMA: | 83.79 | Sell |
8-day EMA: | 62.12 | Sell |
20-day EMA: | 66.92 | Sell |
50-day EMA: | 75.31 | Sell |
200-day EMA: | 81.51 | Sell |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.82 per share, a decrease next quarter of $0.32 per share, a decrease this year of $2.09 per share, and an increase next year of $3.86 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.10 per share, an increase this year of $0.38 per share, and an increase next year of $1.38 per share.
Regeneron Pharmaceuticals Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Triumph Financial Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |